{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:09:52Z","timestamp":1779304192199,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":47,"publisher":"Springer US","isbn-type":[{"value":"9781071648438","type":"print"},{"value":"9781071648445","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-4844-5_12","type":"book-chapter","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T09:34:06Z","timestamp":1760348046000},"page":"151-173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Generation of Donor-Specific iPSC for Modelling Lysosomal Storage Disorders"],"prefix":"10.1007","author":[{"given":"Sueanne","family":"Chear","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adelene","family":"Chiam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryony N.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma J.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex W.","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony L.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"issue":"12","key":"12_CR1","doi-asserted-by":"crossref","first-page":"dmm049651","DOI":"10.1242\/dmm.049651","volume":"15","author":"S Chear","year":"2022","unstructured":"Chear S, Perry S, Wilson R et al (2022) Lysosomal alterations and decreased electrophysiological activity in CLN3 disease patient-derived cortical neurons. Dis Model Mech 15(12):dmm049651","journal-title":"Dis Model Mech"},{"issue":"1","key":"12_CR2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s40478-019-0871-7","volume":"7","author":"G Gomez-Giro","year":"2019","unstructured":"Gomez-Giro G, Arias-Fuenzalida J, Jarazo J et al (2019) Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis. Acta Neuropathol Commun 7(1):222","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"12_CR3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s42003-021-01682-5","volume":"4","author":"C Tang","year":"2021","unstructured":"Tang C, Han J, Dalvi S et al (2021) A human model of Batten disease shows role of CLN3 in phagocytosis at the photoreceptor-RPE interface. Commun Biol 4(1):161","journal-title":"Commun Biol"},{"issue":"10","key":"12_CR4","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.3390\/biom11101412","volume":"11","author":"I Basak","year":"2021","unstructured":"Basak I, Hansen RA, Ward ME et al (2021) Deficiency of the lysosomal protein CLN5 alters lysosomal function and movement. Biomolecules 11(10):1412","journal-title":"Biomolecules"},{"issue":"8","key":"12_CR5","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/hmg\/ddt596","volume":"23","author":"X Lojewski","year":"2014","unstructured":"Lojewski X, Staropoli JF, Biswas-Legrand S et al (2014) Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathway. Hum Mol Genet 23(8):2005\u20132022","journal-title":"Hum Mol Genet"},{"issue":"1","key":"12_CR6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5966\/sctm.2015-0409","volume":"6","author":"Y Sato","year":"2017","unstructured":"Sato Y, Kobayashi H, Higuchi T et al (2017) Metabolomic profiling of Pompe disease-induced pluripotent stem cell-derived Cardiomyocytes reveals that oxidative stress is associated with cardiac and skeletal muscle pathology. Stem Cells Transl Med 6(1):31\u201339","journal-title":"Stem Cells Transl Med"},{"issue":"9","key":"12_CR7","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.ajhg.2023.07.013","volume":"110","author":"M Ter Huurne","year":"2023","unstructured":"Ter Huurne M, Parker BL, Liu NQ et al (2023) GLA-modified RNA treatment lowers GB3 levels in iPSC-derived cardiomyocytes from Fabry-affected individuals. Am J Hum Genet 110(9):1600\u20131605","journal-title":"Am J Hum Genet"},{"issue":"2","key":"12_CR8","volume":"141","author":"V Pham","year":"2024","unstructured":"Pham V, Sertori Finoti L, Cassidy MM et al (2024) A novel iPSC model reveals selective vulnerability of neurons in multiple sulfatase deficiency. Mol Genet Metab 141(2):108116","journal-title":"Mol Genet Metab"},{"issue":"6","key":"12_CR9","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41419-018-0737-0","volume":"9","author":"G Frati","year":"2018","unstructured":"Frati G, Luciani M, Meneghini V et al (2018) Human iPSC-based models highlight defective glial and neuronal differentiation from neural progenitor cells in metachromatic leukodystrophy. Cell Death Dis 9(6):698","journal-title":"Cell Death Dis"},{"key":"12_CR10","volume":"31","author":"MA Hossain","year":"2022","unstructured":"Hossain MA, Hasegawa-Ogawa M, Manome Y et al (2022) Generation and characterization of motor neuron progenitors and motor neurons using metachromatic leukodystrophy-induced pluripotent stem cells. Mol Genet Metab Rep 31:100852","journal-title":"Mol Genet Metab Rep"},{"key":"12_CR11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.mcn.2017.06.007","volume":"83","author":"M Rabenstein","year":"2017","unstructured":"Rabenstein M, Peter F, Joost S et al (2017) Decreased calcium flux in Niemann-Pick type C1 patient-specific iPSC-derived neurons due to higher amount of calcium-impermeable AMPA receptors. Mol Cell Neurosci 83:27\u201336","journal-title":"Mol Cell Neurosci"},{"issue":"622","key":"12_CR12","doi-asserted-by":"crossref","first-page":"eabg2919","DOI":"10.1126\/scitranslmed.abg2919","volume":"13","author":"JV Pluvinage","year":"2021","unstructured":"Pluvinage JV, Sun J, Claes C et al (2021) The CD22-IGF2R interaction is a therapeutic target for microglial lysosome dysfunction in Niemann-Pick type C. Sci Transl Med 13(622):eabg2919","journal-title":"Sci Transl Med"},{"issue":"1","key":"12_CR13","doi-asserted-by":"crossref","first-page":"16644","DOI":"10.1038\/s41598-018-34523-3","volume":"8","author":"N Bayo-Puxan","year":"2018","unstructured":"Bayo-Puxan N, Terrasso AP, Creyssels S et al (2018) Lysosomal and network alterations in human mucopolysaccharidosis type VII iPSC-derived neurons. Sci Rep 8(1):16644","journal-title":"Sci Rep"},{"issue":"1","key":"12_CR14","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.113007","volume":"412","author":"J Hong","year":"2022","unstructured":"Hong J, Cheng YS, Yang S et al (2022) iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II. Exp Cell Res 412(1):113007","journal-title":"Exp Cell Res"},{"issue":"1","key":"12_CR15","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112785","volume":"407","author":"W Huang","year":"2021","unstructured":"Huang W, Cheng YS, Yang S et al (2021) Disease modeling for Mucopolysaccharidosis type IIIB using patient derived induced pluripotent stem cells. Exp Cell Res 407(1):112785","journal-title":"Exp Cell Res"},{"issue":"4","key":"12_CR16","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.stemcr.2015.08.016","volume":"5","author":"I Canals","year":"2015","unstructured":"Canals I, Soriano J, Orlandi JG et al (2015) Activity and high-order effective connectivity alterations in Sanfilippo C patient-specific neuronal networks. Stem Cell Rep 5(4):546\u2013557","journal-title":"Stem Cell Rep"},{"key":"12_CR17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neuroscience.2019.06.026","volume":"414","author":"K Matsushita","year":"2019","unstructured":"Matsushita K, Numakawa T, Odaka H et al (2019) Presynaptic dysfunction in neurons derived from Tay-Sachs iPSCs. Neuroscience 414:128\u2013140","journal-title":"Neuroscience"},{"issue":"3","key":"12_CR18","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1194\/jlr.M081323","volume":"59","author":"ML Allende","year":"2018","unstructured":"Allende ML, Cook EK, Larman BC et al (2018) Cerebral organoids derived from Sandhoff disease-induced pluripotent stem cells exhibit impaired neurodifferentiation. J Lipid Res 59(3):550\u2013563","journal-title":"J Lipid Res"},{"issue":"6","key":"12_CR19","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.stemcr.2021.04.011","volume":"16","author":"E Mangiameli","year":"2021","unstructured":"Mangiameli E, Cecchele A, Morena F et al (2021) Human iPSC-based neurodevelopmental models of globoid cell leukodystrophy uncover patient- and cell type-specific disease phenotypes. Stem Cell Rep 16(6):1478\u20131495","journal-title":"Stem Cell Rep"},{"issue":"1","key":"12_CR20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13023-017-0670-9","volume":"12","author":"F Aguisanda","year":"2017","unstructured":"Aguisanda F, Yeh CD, Chen CZ et al (2017) Neural stem cells for disease modeling of Wolman disease and evaluation of therapeutics. Orphanet J Rare Dis 12(1):120","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"12_CR21","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/jnnp-2022-330851","volume":"94","author":"R Nakamura","year":"2023","unstructured":"Nakamura R, Tohnai G, Nakatochi M et al (2023) Genetic factors affecting survival in Japanese patients with sporadic amyotrophic lateral sclerosis: a genome-wide association study and verification in iPSC-derived motor neurons from patients. J Neurol Neurosurg Psychiatry 94(10):816\u2013824","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"12_CR22","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110913","volume":"39","author":"M Czuppa","year":"2022","unstructured":"Czuppa M, Dhingra A, Zhou Q et al (2022) Drug screen in iPSC-Neurons identifies nucleoside analogs as inhibitors of (G(4)C(2))(n) expression in C9orf72 ALS\/FTD. Cell Rep 39(10):110913","journal-title":"Cell Rep"},{"issue":"10","key":"12_CR23","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/s41591-018-0140-5","volume":"24","author":"K Fujimori","year":"2018","unstructured":"Fujimori K, Ishikawa M, Otomo A et al (2018) Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nat Med 24(10):1579\u20131589","journal-title":"Nat Med"},{"issue":"1","key":"12_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-023-02652-3","volume":"147","author":"JD Rothstein","year":"2023","unstructured":"Rothstein JD, Baskerville V, Rapuri S et al (2023) G(2)C(4) targeting antisense oligonucleotides potently mitigate TDP-43 dysfunction in human C9orf72 ALS\/FTD induced pluripotent stem cell derived neurons. Acta Neuropathol 147(1):1","journal-title":"Acta Neuropathol"},{"issue":"5","key":"12_CR25","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.stemcr.2015.02.022","volume":"4","author":"TA Griffin","year":"2015","unstructured":"Griffin TA, Anderson HC, Wolfe JH (2015) Ex vivo gene therapy using patient iPSC-derived NSCs reverses pathology in the brain of a homologous mouse model. Stem Cell Rep 4(5):835\u2013846","journal-title":"Stem Cell Rep"},{"key":"12_CR26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.omtm.2018.06.005","volume":"10","author":"D Clarke","year":"2018","unstructured":"Clarke D, Pearse Y, Kan SH et al (2018) Genetically corrected iPSC-derived neural stem cell grafts deliver enzyme replacement to affect CNS disease in Sanfilippo B mice. Mol Ther Methods Clin Dev 10:113\u2013127","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"9","key":"12_CR27","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/mt.2015.106","volume":"23","author":"J Doerr","year":"2015","unstructured":"Doerr J, Bockenhoff A, Ewald B et al (2015) Arylsulfatase a overexpressing human iPSC-derived neural cells reduce CNS Sulfatide storage in a mouse model of metachromatic Leukodystrophy. Mol Ther 23(9):1519\u20131531","journal-title":"Mol Ther"},{"issue":"6","key":"12_CR28","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.stem.2023.04.017","volume":"30","author":"S Morimoto","year":"2023","unstructured":"Morimoto S, Takahashi S, Ito D et al (2023) Phase 1\/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery. Cell Stem Cell 30(6):766\u2013780 e769","journal-title":"Cell Stem Cell"},{"key":"12_CR29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/srep00657","volume":"2","author":"L Warren","year":"2012","unstructured":"Warren L, Ni Y, Wang J et al (2012) Feeder-free derivation of human induced pluripotent stem cells with messenger RNA. Sci Rep 2:657","journal-title":"Sci Rep"},{"issue":"5","key":"12_CR30","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","volume":"7","author":"L Warren","year":"2010","unstructured":"Warren L, Manos PD, Ahfeldt T et al (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7(5):618\u2013630","journal-title":"Cell Stem Cell"},{"issue":"5","key":"12_CR31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nmeth.1591","volume":"8","author":"K Okita","year":"2011","unstructured":"Okita K, Matsumura Y, Sato Y et al (2011) A more efficient method to generate integration-free human iPS cells. Nat Methods 8(5):409\u2013412","journal-title":"Nat Methods"},{"issue":"7259","key":"12_CR32","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nature08235","volume":"460","author":"H Hong","year":"2009","unstructured":"Hong H, Takahashi K, Ichisaka T et al (2009) Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460(7259):1132\u20131135","journal-title":"Nature"},{"issue":"3","key":"12_CR33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/cr.2011.12","volume":"21","author":"BK Chou","year":"2011","unstructured":"Chou BK, Mali P, Huang X et al (2011) Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res 21(3):518\u2013529","journal-title":"Cell Res"},{"issue":"1","key":"12_CR34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13287-015-0112-3","volume":"6","author":"AM Drozd","year":"2015","unstructured":"Drozd AM, Walczak MP, Piaskowski S et al (2015) Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP\/EBNA-1 episomal reprogramming system. Stem Cell Res Ther 6(1):122","journal-title":"Stem Cell Res Ther"},{"issue":"5928","key":"12_CR35","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1172482","volume":"324","author":"J Yu","year":"2009","unstructured":"Yu J, Hu K, Smuga-Otto K et al (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science 324(5928):797\u2013801","journal-title":"Science"},{"issue":"1","key":"12_CR36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nbt.3070","volume":"33","author":"TM Schlaeger","year":"2015","unstructured":"Schlaeger TM, Daheron L, Brickler TR et al (2015) A comparison of non-integrating reprogramming methods. Nat Biotechnol 33(1):58\u201363","journal-title":"Nat Biotechnol"},{"key":"12_CR37","volume":"53","author":"L Ma","year":"2021","unstructured":"Ma L, Prada AM, Schmidt M et al (2021) Generation of pathogenic TPP1 mutations in human stem cells as a model for neuronal ceroid lipofuscinosis type 2 disease. Stem Cell Res 53:102323","journal-title":"Stem Cell Res"},{"key":"12_CR38","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.754045","volume":"12","author":"E Gardner","year":"2021","unstructured":"Gardner E, Mole SE (2021) The genetic basis of phenotypic heterogeneity in the neuronal ceroid Lipofuscinoses. Front Neurol 12:754045","journal-title":"Front Neurol"},{"key":"12_CR39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/7651_2021_421","volume":"2549","author":"J Talbot","year":"2022","unstructured":"Talbot J, Chear S, Phipps A et al (2022) Image-based quantitation of Kainic acid-induced Excitotoxicity as a model of neurodegeneration in human iPSC-derived neurons. Methods Mol Biol 2549:187\u2013207","journal-title":"Methods Mol Biol"},{"issue":"1","key":"12_CR40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13287-024-03671-x","volume":"15","author":"NE King","year":"2024","unstructured":"King NE, Courtney JM, Brown LS et al (2024) Induced pluripotent stem cell derived pericytes respond to mediators of proliferation and contractility. Stem Cell Res Ther 15(1):59","journal-title":"Stem Cell Res Ther"},{"key":"12_CR41","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymeth.2021.02.009","volume":"194","author":"Q Wang","year":"2021","unstructured":"Wang Q, Chear S, Wing K et al (2021) Use of CRISPR\/Cas ribonucleoproteins for high throughput gene editing of induced pluripotent stem cells. Methods 194:18\u201329","journal-title":"Methods"},{"issue":"1","key":"12_CR42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13059-021-02293-3","volume":"22","author":"D Neavin","year":"2021","unstructured":"Neavin D, Nguyen Q, Daniszewski MS et al (2021) Single cell eQTL analysis identifies cell type-specific genetic control of gene expression in fibroblasts and reprogrammed induced pluripotent stem cells. Genome Biol 22(1):76","journal-title":"Genome Biol"},{"key":"12_CR43","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2021.102568","volume":"57","author":"A Mehta","year":"2021","unstructured":"Mehta A, Lu P, Taylor BV et al (2021) Generation of MNZTASi001-A, a human pluripotent stem cell line from a person with primary progressive multiple sclerosis. Stem Cell Res 57:102568","journal-title":"Stem Cell Res"},{"key":"12_CR44","first-page":"1 27 21","volume":"79","author":"CF Lin","year":"2013","unstructured":"Lin CF, Naj AC, Wang LS (2013) Analyzing copy number variation using SNP array data: protocols for calling CNV and association tests. Curr Protoc Hum Genet 79:1 27 21\u201321 27 15","journal-title":"Curr Protoc Hum Genet"},{"issue":"11","key":"12_CR45","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1101\/gr.6861907","volume":"17","author":"K Wang","year":"2007","unstructured":"Wang K, Li M, Hadley D et al (2007) PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res 17(11):1665\u20131674","journal-title":"Genome Res"},{"issue":"6","key":"12_CR46","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1093\/nar\/gkm076","volume":"35","author":"S Colella","year":"2007","unstructured":"Colella S, Yau C, Taylor JM et al (2007) QuantiSNP: an objective Bayes hidden-Markov model to detect and accurately map copy number variation using SNP genotyping data. Nucleic Acids Res 35(6):2013\u20132025","journal-title":"Nucleic Acids Res"},{"key":"12_CR47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11103-012-9885-2","volume":"80","author":"F Xie","year":"2012","unstructured":"Xie F, Xiao P, Chen D et al (2012) miRDeepFinder: a miRNA analysis tool for deep sequencing of plant small RNAs. Plant Mol Biol 80:75","journal-title":"Plant Mol Biol"}],"container-title":["Methods in Molecular Biology","Lysosomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4844-5_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:47:39Z","timestamp":1779302859000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4844-5_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"ISBN":["9781071648438","9781071648445"],"references-count":47,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4844-5_12","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"14 October 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}